Pdp (68071 3464 3)
Gabapentin
Product Images NDC 68071-3464
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68071-3464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image Description (Gabapentincapsules 01)
This text appears to be a formula for calculating age-adjusted weight and creatinine clearance (CLCr) using a patient's age, weight, and serum creatinine levels. The formula includes multiplying age (in years) by weight (in kilograms) to obtain the result. Then, CLCr is calculated by multiplying 72 by the serum creatinine level measured in milligrams per deciliter (mg/dL). Additionally, for female patients, the calculated CLCr should be multiplied by 0.85.*
Chemical Structure (Gabapentincapsules 02)
Figure 1 (Gabapentincapsules 03)
The text provided appears to be a part of a evaluation or measurement related to pain scores. It mentions "Mean Pain Score" and includes some numbers, but without further context or readable information, it is not possible to provide a specific description.*
Figure 2 (Gabapentincapsules 04)
Figure 3 (Gabapentincapsules 05)
Figure 4 (Gabapentincapsules 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
